Researchers at Emory University have developed a novel anti-tumor compound that represents a distinct strategy: targeting one of the most important "intercept points" for cancer cells.
The Food and Drug Administration and pharmaceutical giant Merck have agreed on a "special protocol assessment" that will determine if the cancer drug oral deforolimus for patients with cancer of the body's connective tissue(s).
The Journal of the National Cancer Institute published a study that stated -- a sharp decline in the use of premenopausal hormones was followed by a drop in the rate of breast cancer.
A study published in the journal Cancer says that improvements in the treatment of metastatic breast cancer are making a difference and patients are living longer with the disease.
Sure Touch is a unique digital sensing device that assists a physician or other health care professional in screening for breast cancer during routine exams.
Clinical Trials
